Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study

RATIONALE: Long-acting injectable antipsychotic therapies may offer benefits over oral antipsychotics in patients with schizophrenia. OBJECTIVE: This study aimed to explore the safety, tolerability, and treatment response of paliperidone palmitate once-monthly in non-acute but symptomatic adult pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiner, Andreas, Caspi, Asaf, Bergmans, Paul, Cherubin, Pierre, Keim, Sofia, Lara, Elsa, Pinchuk, Irina, Schuepbach, Daniel, Suleman, Sajid, Hargarter, Ludger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203852/
https://www.ncbi.nlm.nih.gov/pubmed/27815602
http://dx.doi.org/10.1007/s00213-016-4445-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5203852/
https://www.ncbi.nlm.nih.gov/pubmed/27815602
http://dx.doi.org/10.1007/s00213-016-4445-0

Ejemplares similares